Seeking Alpha
View as an RSS Feed

EP Vantage  

View EP Vantage's Articles BY TICKER:
  • IPOs Mean Diminishing Returns For Medtech VCs
    Fri, Jul. 10 GKOS, IRMD, LENS Comment!
  • Biotech Bull Market Boosts IPO Bumps
    Fri, Jul. 10 CATB, ADAP, KMPH Comment!
  • Entresto Approval Revives Heart Failure Sector
    Thu, Jul. 9 NVS 1 Comment
  • Medtech On Course For $100bn In Mergers By Year-End
    Tue, Jul. 7 Comment!
  • Sector's Smaller Players Show The Way
    Sat, Jul. 4 CELG, JUNO, PBYI Comment!
  • No Letting Up In Pharma As First-Half Gains Outweigh Losses
    Fri, Jul. 3 PJP, XPH, IHE 2 Comments
  • Medtech Floats Remain Steady In 2015
    Fri, Jul. 3 GKOS 1 Comment
  • Celgene Goes For Broke
    Thu, Jul. 2 CELG 15 Comments
  • Big Pharma Picks Immunocore As A Cell Therapy Player To Watch
    Tue, Jun. 30 LLY 1 Comment
  • Bluebird Feathers Nest While Going Is Good
    Thu, Jun. 25 BLUE 4 Comments
  • Bone Up On First Osteoporosis Data
    Wed, Jun. 24 BNZPF 1 Comment
  • Asco Value Scale Eases Payers' Workloads
    Wed, Jun. 24 CVS, ESRX, RHHBY Comment!
  • TAVI Approvals Just The Latest From More Relaxed FDA
    Wed, Jun. 24 MDT, EW Comment!
  • Small Deals The New Norm For Big Spender Medtronic
    Tue, Jun. 23 MDT Comment!
  • Upcoming Events: Vital Data For Merck's Lantus Biosimilar And Biogen's Neublastin
    Fri, Jun. 19 IBB, XBI, LLY Comment!
  • $2 Billion Buy Moves Hill-Rom Away From The Hospital
    Fri, Jun. 19 HRC Comment!
  • Edwards Tightens Transcatheter Valve Stranglehold
    Fri, Jun. 19 EW 2 Comments
  • It's A Novartis World - Everybody Else Just Lives In It
    Wed, Jun. 17 NVS 3 Comments
  • TransEnterix Goes Where Intuitive Cannot
    Tue, Jun. 16 ISRG, TRXC 5 Comments
  • Upcoming Events: Data From Redhill In Ulcers And Ascendis In Growth Deficiencies
    Fri, Jun. 12 RDHL, ASND 2 Comments
  • FDA's High Bar For Breakthrough Therapy Designations
    Mon, Jun. 8 SNY 2 Comments
  • Shire Needs To Acquire, And Actelion Fits The Bill
    Mon, Jun. 8 ALIOF, ALIOY 1 Comment
  • Roche On The Wrong Side For Once In Shifting Analyst Forecasts
    Sat, Jun. 6 IBB, RHHBF, RHHBY Comment!
  • Opko Bolsters Both Drugs And Diagnostics With $1.5bn Labs Buy
    Fri, Jun. 5 OPK 29 Comments
  • Big Downgrades Outweigh Upgrades For Pharma's Biggest Products
    Fri, Jun. 5 GILD, ABBV, MRK 4 Comments
  • ASCO Event Analyzer - 2015's Winners And Losers
    Thu, Jun. 4 BMY, PBYI, IMGN 1 Comment
  • Asco - Sirtex Spins Surrogate Hit But No Chance For First-Line Use
    Thu, Jun. 4 SXMDF Comment!
  • ASCO - Surprise Boost For ImmunoGen In Ovarian Cancer
    Tue, Jun. 2 IMGN 1 Comment
  • ASCO - Puma May Have To Rely On Extended Follow-Up
    Tue, Jun. 2 PBYI 4 Comments
  • FTC Sees Too Much Synergy In Steris Deal
    Mon, Jun. 1 STE, SYHEF Comment!
  • Asco- Earlier Taxotere Use Could Give Jevtana New Lease Of Life
    Mon, Jun. 1 SNY 1 Comment
  • Asco - A Sirius Lead For Daratumumab
    Mon, Jun. 1 GMXAY, GNMSF Comment!